10 Best Retirement Stocks to Buy According to Hedge Funds

3. Pfizer Inc. (NYSE:PFE)

Beta Value: 0.58

Dividend Yield: 6.54%

Number of Hedge Fund Holders: 92

Pfizer Inc. (NYSE:PFE) is a leading global pharmaceutical company that develops, produces, and sells biopharmaceutical medicines worldwide.

Pfizer Inc. (NYSE:PFE) announced full-year 2024 revenues of $63.6 billion, representing a 7% year-over-year operational rise; removing contributions from Paxlovid and Comirnaty, revenues increased 12% operationally.

On February 11, Jefferies analyst Akash Tewari increased Pfizer Inc.’s (NYSE:PFE) price objective from $33 to $34, while keeping a Buy rating on the stock. The shift occurred following the release of Pfizer’s abstract on mevrometostat (EZH2i) at the American Society of Clinical Oncology Genitourinary conference. Tewari added that the new findings might have a positive impact on Pfizer’s ongoing Phase 3 studies in both post-abiraterone and first-line metastatic castration-resistant prostate cancer (mCRPC) circumstances.